Yokohama City University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Yokohama City University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014171
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yokohama City University (YCU) is an educational university that provides various undergraduate and graduate courses. The institute offers graduate program in various courses such as international management, nanobioscience, medical life science and medicine. It conducts research that contributes to advanced technology. YCU also partners with local medical institutions for the promotion of patient oriented care. The institute operates through its campuses including Kanazawa-hakkei Campus, Fukuura Campus, Maioka Campus and Tsurumi Campus. It also operates research centers. YCU is headquartered in Yokohama, Japan.

Yokohama City University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yokohama City University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yokohama City University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yokohama City University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yokohama City University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Yokohama City University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Yokohama City University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CiRA, Takeda Pharma and Yokohama City University Enter into Research Agreement 10
Chiome Bioscience Enters Into Co-Development Agreement With Yokohama City University 11
Licensing Agreements 12
Horizon Discovery Enters Into Licensing Agreement With Yokohama City University For X-MAN Cell Lines 12
Yokohama City University – Key Competitors 13
Yokohama City University – Key Employees 14
Yokohama City University – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Yokohama City University, Pharmaceuticals & Healthcare, Key Facts 2
Yokohama City University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yokohama City University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yokohama City University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yokohama City University, Deals By Therapy Area, 2011 to YTD 2017 8
Yokohama City University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CiRA, Takeda Pharma and Yokohama City University Enter into Research Agreement 10
Chiome Bioscience Enters Into Co-Development Agreement With Yokohama City University 11
Horizon Discovery Enters Into Licensing Agreement With Yokohama City University For X-MAN Cell Lines 12
Yokohama City University, Key Competitors 13
Yokohama City University, Key Employees 14
Yokohama City University, Other Locations 15
Yokohama City University, Subsidiaries 15

★海外企業調査レポート[Yokohama City University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProAxsis Ltd:製品パイプライン分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …
  • Luna Innovations Inc (LUNA):企業の財務・戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a in …
  • Al Kamil Power Company SAOG (KPCS):企業の財務・戦略的SWOT分析
    Al Kamil Power Company SAOG (KPCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Concord New Energy Group Ltd (182):電力:M&Aディール及び事業提携情報
    Summary Concord New Energy Group Limited (Concord), formerly China WindPower Group Limited, is a clean and renewable energy company that carries out the construction, operation and maintenance of, and investment in, wind and solar power electricity generating facilities in China. Concord’s core busi …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Marac Electronics S.A.:企業の戦略・SWOT・財務情報
    Marac Electronics S.A. - Strategy, SWOT and Corporate Finance Report Summary Marac Electronics S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ubisoft Entertainment SA (UBI):企業の財務・戦略的SWOT分析
    Ubisoft Entertainment SA (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Sete Brasil Participacoes SA:企業の戦略的SWOT分析
    Sete Brasil Participacoes SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Industrial Bank Of Korea:企業の戦略・SWOT・財務分析
    Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Younicos AG:電力:M&Aディール及び事業提携情報
    Summary Younicos AG (Younicos), a subsidiary of Aggreko Plc, is a provider of smart energy and grid solutions based on battery storage technology. The company offers Y-Cube plug and play energy storage solution, Y-Station building solution, and Y-Q software platform. It also provides battery packs u …
  • Cabela’s Incorporated:戦略・SWOT・企業財務分析
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SurModics Inc (SRDX)-医療機器分野:企業M&A・提携分析
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Centrexion Therapeutics Corp (CNTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆